Cargando…
Comment on “Cost-Effectiveness of Cannabidiol Adjunct Therapy Versus Usual Care for the Treatment of Seizures in Lennox-Gastaut Syndrome”
Autores principales: | Hollenack, Kelly, Marshall, Jade |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009776/ https://www.ncbi.nlm.nih.gov/pubmed/33674999 http://dx.doi.org/10.1007/s40273-021-01005-w |
Ejemplares similares
-
Lennox-Gastaut syndrome: An overview
por: Ramanathan, Ramnath Santhosh, et al.
Publicado: (2010) -
Clobazam as an adjunctive therapy in treating seizures associated with Lennox–Gastaut syndrome
por: Leahy, Jennifer T, et al.
Publicado: (2011) -
Cannabidiol for epilepsy (Lennox-Gastaut syndrome, Dravet syndrome)
Publicado: (2020) -
Cannabidiol for Treating Lennox-Gastaut Syndrome and Dravet Syndrome in Korea
por: Koo, Chung Mo, et al.
Publicado: (2020) -
Anaesthetic management in a patient with Lennox-Gastaut syndrome
por: Dhansura, Tasneem, et al.
Publicado: (2014)